OMX Copenhagen 20 Gains 1.16% to Hit One-Month High, Genmab Surges

Danish equities advanced at the close of trading on Monday, with the benchmark OMX Copenhagen 20 index rising 1.16% to reach a new one-month high. The gains were led by strong performance in the consumer goods, personal & household goods, and chemicals sectors, according to market data.

Index Movers

The positive sentiment was reflected in the market's breadth, as advancing stocks on the Copenhagen Stock Exchange outnumbered decliners by a margin of 81 to 47, with 10 stocks ending the session unchanged.

Leading the charge on the OMXC20 was biotechnology company Genmab (CSE:GMAB), which saw its shares soar 12.10% to close at 2,964.00, a new three-year high. Shipping giant A.P. Moeller - Maersk also posted significant gains, with its Class B shares (CSE:MAERSKb) climbing 4.02% and its Class A shares (CSE:MAERSKa) rising 3.87%.

On the downside, the session's worst performers included Novozymes AS (CSE:NSISb), which fell 2.64%. Zealand Pharma A/S (CSE:ZELA) declined by 1.19%, and Coloplast A/S (CSE:COLOb) was down 0.89%.

Ad

Broader Market Context

In the commodities market, oil prices were mixed. Crude oil for December delivery slipped 0.25% to $103.01 a barrel, while Brent oil for January delivery rose 0.40% to $112.15 a barrel. Gold futures for December delivery gained 0.63% to trade at $4,033.30 a troy ounce.

In currency markets, the Danish krone was little changed against the euro, with the EUR/DKK pair at 7.47. The krone weakened slightly against the U.S. dollar, with the USD/DKK pair rising 0.19% to 6.68. The U.S. Dollar Index Futures, which measures the greenback against a basket of other major currencies, was up 0.17%.